These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 30282547)

  • 21. Skin graft loss resulting from collagenase clostridium histolyticum treatment of Dupuytren contracture: case report and review of the literature.
    Swanson JW; Watt AJ; Vedder NB
    J Hand Surg Am; 2013 Mar; 38(3):548-51. PubMed ID: 23391354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Collagenase Clostridium histolyticum for the Treatment of Distal Interphalangeal Joint Contractures in Dupuytren Disease.
    Fei TT; Chernoff E; Monacco NA; Komatsu DE; Muhlrad S; Sampson SP; Hurst LC; Dagum AB
    J Hand Surg Am; 2019 May; 44(5):417.e1-417.e4. PubMed ID: 30146387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Injectable collagenase Clostridium histolyticum: a new nonsurgical treatment for Dupuytren's disease.
    Gilpin D; Coleman S; Hall S; Houston A; Karrasch J; Jones N
    J Hand Surg Am; 2010 Dec; 35(12):2027-38.e1. PubMed ID: 21134613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clostridium histolyticum collagenase in the treatment of Dupuytren's contracture.
    Azzopardi E; Boyce DE
    Br J Hosp Med (Lond); 2012 Aug; 73(8):432-6. PubMed ID: 22875519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-Term Effects of the Collagenase of the Bacterium Clostridium histolyticum for the Treatment of Capsular Fibrosis After Silicone Implants.
    Fischer S; Diehm Y; Henzler T; Berger MR; Kolbenschlag J; Latz A; Bueno EM; Hirche C; Kneser U; Pomahac B
    Aesthetic Plast Surg; 2017 Feb; 41(1):211-220. PubMed ID: 28008464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Injectable collagenase clostridium histolyticum for Dupuytren's contracture.
    Hurst LC; Badalamente MA; Hentz VR; Hotchkiss RN; Kaplan FT; Meals RA; Smith TM; Rodzvilla J;
    N Engl J Med; 2009 Sep; 361(10):968-79. PubMed ID: 19726771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. More tips for collagenase injections.
    Denkler K
    J Hand Surg Am; 2014 Oct; 39(10):2120-1. PubMed ID: 25257494
    [No Abstract]   [Full Text] [Related]  

  • 28. Using Tongue Depressors as a Technique to Aid Cord Localization During Collagenase Injection For Dupuytren Disease.
    Mehdi SK; Yonz MC; Keshtvarz S; Kamineni S; Dhawan V
    Tech Hand Up Extrem Surg; 2019 Dec; 23(4):196-198. PubMed ID: 31738740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of Collagenase Treatment for Dupuytren Disease.
    Badalamente MA; Hurst LC
    Hand Clin; 2018 Aug; 34(3):345-349. PubMed ID: 30012294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bringing It All Together: A Practical Approach to the Treatment of Dupuytren Disease.
    Haase SC; Chung KC
    Hand Clin; 2018 Aug; 34(3):427-436. PubMed ID: 30012302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Collagenase Treatment for Dupuytren Disease of the Thumb and First Web.
    Dreise MM; Stenekes MW; Werker PM
    J Hand Surg Am; 2016 Mar; 41(3):348-53.e1. PubMed ID: 26803569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Minimally Invasive Treatments of Dupuytren Disease: An Overview.
    Yeo JH; Kim JY
    J Hand Surg Asian Pac Vol; 2021 Jun; 26(2):131-141. PubMed ID: 33928844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discussion: Collagenase Clostridium Histolyticum for Dupuytren Contracture: Comparing Single and Concurrent Injections.
    Lalonde DH
    Plast Reconstr Surg; 2019 Apr; 143(4):788e-789e. PubMed ID: 30921133
    [No Abstract]   [Full Text] [Related]  

  • 34. A
    Pess GM; Sundbom M; Wilson K; Lindqvist D; Dahlin LB
    J Plast Surg Hand Surg; 2018 Oct; 52(5):301-306. PubMed ID: 30039732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ▾Xiapex for Dupuytren's contracture.
    Drug Ther Bull; 2011 Dec; 49(12):138-41. PubMed ID: 22170410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Skin laceration as a serious adverse sequela of injectable collagenase for Dupuytren contracture.
    Hallock GG
    Plast Reconstr Surg; 2012 Jan; 129(1):205e-206e. PubMed ID: 22186568
    [No Abstract]   [Full Text] [Related]  

  • 37. Advances in Minimally Invasive Treatment of Dupuytren Disease.
    Hovius SER; Zhou C
    Hand Clin; 2018 Aug; 34(3):417-426. PubMed ID: 30012301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative Outcomes of Dupuytren Disease Treatment.
    Binhammer P
    Hand Clin; 2018 Aug; 34(3):377-386. PubMed ID: 30012297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective randomized controlled trial comparing 1- versus 7-day manipulation following collagenase injection for dupuytren contracture.
    Mickelson DT; Noland SS; Watt AJ; Kollitz KM; Vedder NB; Huang JI
    J Hand Surg Am; 2014 Oct; 39(10):1933-1941.e1. PubMed ID: 25194768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dupuytren Cords Do Not Undergo Significant Histopathological Change After Collagenase Clostridium Histolyticum Injection.
    Guo M; Yang K; Kock ND; Daley R; Dzwierzynski W; LoGiudice J; Hettinger P; Best C; Argenta A
    Hand (N Y); 2023 Sep; 18(6):912-917. PubMed ID: 35081825
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.